Potassium-Sparing Diuretics: Examples and Clinical Use
The three main potassium-sparing diuretics are amiloride, triamterene, and spironolactone 1, 2, 3, 4.
Primary Examples
Epithelial Sodium Channel (ENaC) Blockers
- Amiloride: Initial dose 2.5-5 mg daily, maximum 20-40 mg daily 1, 2
- Triamterene: Initial dose 25-50 mg daily, maximum 100-200 mg daily 1, 2
Mineralocorticoid Receptor Antagonists (Aldosterone Antagonists)
- Spironolactone: Initial dose 25 mg daily, maximum 50-200 mg daily 1, 2, 3
- Eplerenone: Initial dose 50 mg daily, maximum 100 mg daily 2
Clinical Context and Indications
These agents should only be used when hypokalaemia persists despite ACE inhibitor therapy and standard diuretics 1, 5, 1, 6. The European Heart Journal guidelines consistently emphasize this restricted indication across multiple publications 1, 6.
Specific Clinical Scenarios
In heart failure: Spironolactone is recommended in advanced heart failure (NYHA class III-IV) in addition to ACE inhibition and diuretics to improve survival and morbidity 5. The 2022 ACC/AHA/HFSA guidelines note that mineralocorticoid receptor antagonists reduce hospitalizations and prolong survival 4.
In resistant hypertension: Spironolactone 25-50 mg daily is preferred, with eplerenone as an alternative if sexual side effects occur 2, 7. The 2018 ACC/AHA hypertension guidelines classify these as secondary agents for blood pressure management 2.
Critical Safety Considerations
Monitoring Requirements
- Check serum potassium and creatinine after 5-7 days of initiation, then recheck every 5-7 days until values are stable 1, 5, 1, 6
- After stabilization, monitor every 3-6 months 1
Major Contraindications and Warnings
- Avoid during ACE inhibitor initiation 1, 5, 1
- Avoid in significant CKD (e.g., GFR <45 mL/min for amiloride/triamterene) 2
- Do not combine with potassium supplements without close monitoring 2
- Major side effect: Hyperkalaemia for all agents 1
- Spironolactone specifically causes gynaecomastia and impotence 1
- Amiloride may cause rash 1
Practical Prescribing Algorithm
Confirm indication: Persistent hypokalaemia despite ACE inhibitor + standard diuretic therapy, OR advanced heart failure (for spironolactone), OR resistant hypertension (for aldosterone antagonists)
Start low dose: Begin with amiloride 2.5 mg, triamterene 25 mg, or spironolactone 25 mg daily 1
Monitor closely: Check potassium and creatinine at 5-7 days 1, 5, 1, 6
Titrate carefully: Adjust dose based on potassium levels, rechecking every 5-7 days until stable 1
Long-term surveillance: Continue monitoring every 3-6 months 1
Important Clinical Pearls
Potassium-sparing diuretics are minimally effective as monotherapy for blood pressure reduction 2, 8. They are most commonly prescribed in fixed-dose combinations with thiazide diuretics (e.g., hydrochlorothiazide + triamterene or amiloride) to prevent hypokalaemia 2, 9, 10.
The combination of thiazides with potassium-sparing agents provides better blood pressure control while minimizing hypokalaemia and hyperglycaemia compared to thiazides alone 10. This makes combination therapy preferable to thiazide monotherapy when treating hypertension.